2022 Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Hind Alotaibi Journal Transplant Cell Ther.
2022 Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Stavroula Masouridi-Levrat Journal Bone Marrow Transplant.